7XY8
Crystal structure of antibody Fab fragment in complex with CD147(EMMPIRIN)
Summary for 7XY8
| Entry DOI | 10.2210/pdb7xy8/pdb |
| Descriptor | Isoform 2 of Basigin, heavy chain, light chain, ... (4 entities in total) |
| Functional Keywords | cd147, complex, antibody, protein binding |
| Biological source | Homo sapiens (human) More |
| Total number of polymer chains | 6 |
| Total formula weight | 142428.30 |
| Authors | Nakamura, K.,Amano, M.,Yoneda, K.,Suzuki, M.,Fukuchi, K. (deposition date: 2022-06-01, release date: 2022-11-23, Last modification date: 2024-10-16) |
| Primary citation | Fukuchi, K.,Nanai, K.,Yuita, H.,Maru, C.,Tsukada, J.,Ishigami, M.,Nagai, Y.,Nakano, Y.,Yoshimura, C.,Yoneda, K.,Amano, M.,Nakamura, K.,Oda, Y.,Nishigohri, H.,Yamamoto, S.,Ohnishi-Totoki, Y.,Inaki, K.,Komori, H.,Nakano, R.,Kanari, Y.,Nishida, A.,Matsui, Y.,Funo, S.,Takahashi, S.,Ohtsuka, T.,Agatsuma, T. Novel Antibody Exerts Antitumor Effect through Downregulation of CD147 and Activation of Multiple Stress Signals. J Oncol, 2022:3552793-3552793, 2022 Cited by PubMed Abstract: CD147 is an immunoglobulin-like receptor that is highly expressed in various cancers and involved in the growth, metastasis, and activation of inflammatory pathways via interactions with various functional molecules, such as integrins, CD44, and monocarboxylate transporters. Through screening of CD147-targeting antibodies with antitumor efficacy, we discovered a novel rat monoclonal antibody 147D. This humanized IgG4-formatted antibody, h4147D, showed potent antitumor efficacy in xenograft mouse models harboring the human PDAC cell line MIA PaCa-2, HCC cell line Hep G2, and CML cell line KU812, which featured low sensitivity to the corresponding standard-of-care drugs (gemcitabine, sorafenib, and imatinib, respectively). An analysis of tumor cells derived from MIA PaCa-2 xenograft mice treated with h4147D revealed that cell surface expression of CD147 and its binding partners, including CD44 and integrin 31/61, was significantly reduced by h4147D. Inhibition of focal adhesion kinase (FAK), activation of multiple stress responsible signal proteins such as c-JunN-terminal kinase (JNK) and mitogen-activated protein kinase p38 (p38MAPK), and expression of SMAD4, as well as activation of caspase-3 were obviously observed in the tumor cells, suggesting that h4147D induced tumor shrinkage by inducing multiple stress responsible signals. These results suggest that the anti-CD147 antibody h4147D offers promise as a new antibody drug candidate. PubMed: 36385956DOI: 10.1155/2022/3552793 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.3 Å) |
Structure validation
Download full validation report
